Amwell® to report first quarter 2026 operating results
Rhea-AI Summary
Amwell (NYSE: AMWL) will report first quarter 2026 operating results after market close on Tuesday, May 5, 2026. The management team will host a live conference call and webcast at 5:00 p.m. ET to review the results and provide a business update.
The full earnings report and live audio webcast will be available in the Investors section of the company's website, with a webcast replay accessible at investors.amwell.com for approximately 90 days.
AI-generated analysis. Not financial advice.
Positive
- None.
Negative
- None.
News Market Reaction – AMWL
On the day this news was published, AMWL declined 4.54%, reflecting a moderate negative market reaction. Argus tracked a peak move of +4.7% during that session. Argus tracked a trough of -2.0% from its starting point during tracking. Our momentum scanner triggered 11 alerts that day, indicating notable trading interest and price volatility. This price movement removed approximately $5M from the company's valuation, bringing the market cap to $110.40M at that time.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
Peers show mixed moves: CCLD down 1.6%, HCAT up 2.33%, SOPH up 2.13%, MNDR up 3.26%, FORA flat. This points to stock-specific trading around this earnings-date notice.
Previous Earnings date Reports
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Feb 05 | Earnings date notice | Neutral | +4.5% | Announced timing and access details for Q4 and full-year 2025 results. |
Limited history for earnings-date notices; the prior event saw a modest positive move.
Recent news for Amwell has centered on earnings communications, conferences, and equity awards. A prior earnings date notice on Feb 5, 2026 preceded a 4.47% gain, while actual earnings releases in Feb 2026 and Nov 2025 produced larger moves in both directions. Today’s announcement again outlines timing and access details for the next quarterly report and webcast, consistent with the company’s established investor-relations cadence.
Historical Comparison
In the past, AMWL had one earnings-date notice, linked to a 4.47% move. Today’s release is structurally similar, mainly setting expectations for the upcoming Q1 2026 report and webcast.
Earnings-date communications continue the pattern of pre-announcing result timing and webcast details before full quarterly reports.
Market Pulse Summary
This announcement sets the timetable for Amwell’s Q1 2026 results, with a report after the close on May 5 and a 5 p.m. ET call plus webcast replay for about 90 days. It continues the company’s pattern of pre-announcing earnings dates and access details. Investors may focus on how upcoming financials compare with prior quarters and should monitor subsequent earnings releases and related filings for concrete performance and outlook signals.
AI-generated analysis. Not financial advice.
BOSTON, April 20, 2026 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, will report first quarter 2026 operating results after stock market trading hours on Tuesday, May 5.
Following the distribution of the earnings alert via wire services, the Amwell management team will host a live conference call and webcast at 5 p.m. ET to review the company's operating results and provide a general business update.
The full earnings report and the live audio webcast can be accessed by visiting the Investors section of the company's website. A webcast replay of the call will be available at investors.amwell.com for approximately 90 days.
About Amwell
Amwell offers payers and health systems a single, comprehensive, technology-enabled care platform. We use technology to provide patients with better access to more convenient, affordable and effective care. The Amwell platform includes software and services that power many clinical programs from Amwell and our growing number of partners. Our platform allows patients to experience unified, personalized and simple access to diversified clinical programs across the care continuum. As more people seek care online and more clinical programs become available, we offer integrated, future-ready, consistent solutions. The Amwell platform is proven, operating at a large scale, enabling care for millions of patients and their sponsors while delivering dependable outcomes. For almost two decades, Amwell has proudly served some of the largest and most sophisticated healthcare organizations in the U.S. and worldwide. For more information, visit business.amwell.com or LinkedIn.
Investors:
Asher Dewhurst
Media:
